apollo
0
  1. Home
  2. salt
  3. Trinbelimab

Trinbelimab

About Trinbelimab

Trinbelimab is used to prevent Rh sensitization in Rh-negative individuals, especially during pregnancy and after certain medical procedures. Rh sensitization occurs when an Rh-negative individual is exposed to Rh-positive red blood cells, leading their immune system to produce antibodies against the Rh factor. This can happen during pregnancy if an Rh-negative mother carries an Rh-positive baby, or through blood transfusions with Rh-positive blood.

Trinbelimab contains Trinbelimad, which belongs to the class of drugs called immunoglobulins. It works by eliminating or neutralizing any Rh D-positive fetal red blood cells that may enter the Rh D-negative mother's bloodstream during childbirth, abortion, or any pregnancy-related complications that could cause bleeding across the placenta.

The dose and duration of treatment with Trinbelimab may vary depending on your medical condition. Trinbelimab usually does not have any known side effect. However, in some cases, it may cause some side effects, including local pain, fever, flushing, headache, and chills, which may occur after administration. Most of these side effects are temporary and resolve on their own. It is essential to consult your doctor if they persist or worsen over time.

Inform your doctor if you are allergic to Trinbelimab. Also inform your doctor about all the medicines you are taking and about your pre-existing health conditions. Trinbelimab is for intramuscular use only, do not inject intravenously. It is for maternal administration. Do not inject the new-born infant. Trinbelimab is contraindicated in pregnant woman with positive ICT (Indirect Coombs' test) and Rh-D positive.

Uses of Trinbelimab

Trinbelimab is used in the treatment of Rh sensitization in Rh-negative individuals, especially during pregnancy and after certain medical procedures. The detailed uses of Trinbelimab are as follows: • Rh sensitization: Trinbelimab is used in the treatment of Rh sensitization in Rh-negative mothers carrying Rh-positive fetuses. • Prevention of Hemolytic Disease of the Newborn (HDN): Trinbelimab reduces the risk of hemolytic disease in newborns (HDN) by preventing the mother's immune system from attacking fetal red blood cells.

Medicinal Benefits

Trinbelimab is used to prevent Rh sensitization in individuals with Rh-negative blood. It is typically given to Rh-negative pregnant women within 72 hours after delivery if the baby is Rh-positive. This helps prevent the mother's immune system from reacting to Rh-positive red blood cells. Additionally, it is used in Rh-negative individuals who receive Rh-positive blood transfusions to prevent an immune reaction.

Directions for Use

  • Follow your doctor’s instructions on the dosage and timing of this medication.
  • Trinbelimab is administered by the doctor or nurse in a healthcare setting.
  • Do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Trinbelimab

  • Local pain
  • Fever
  • Flushing
  • Headache
  • Chills

Drug Warnings

Trinbelimab is for intramuscular use only, do not inject intravenously. It is for maternal administration. Do not inject the new-born infant. Trinbelimab is contraindicated in pregnant woman with positive ICT (Indirect Coombs' test) and Rh-D positive. Inform your doctor if you are allergic to Trinbelimab. Also inform your doctor about all the medicines you are taking and about your pre-existing health conditions.

Drug Interactions

Drug-Drug Interactions: No interactions were found/established.

Drug-Food Interactions: No interactions were found/established.

Dug-Disease Interactions: No interactions were found/established.

Drug-Drug Interactions Checker List:

Safety Advice

  • Safety Warning

    Alcohol

    consult your doctor

    It is unknown whether Trinbelimab interacts with alcohol. Consult your doctor for more information.

  • Safety Warning

    Pregnancy

    caution

    Trinbelimab is contraindicated in pregnant woman with positive ICT (Indirect Coombs' test) and who is Rh-D positive. Trinbelimab does not harm the fetus or affect future pregnancies or the reproduction capacity of the maternal recipient. Trinbelimab is intended for use in other sensitizing events during pregnancy.

  • Safety Warning

    Breast Feeding

    consult your doctor

    Please inform your doctor if you are breastfeeding, before receiving Trinbelimab.

  • Safety Warning

    Driving

    consult your doctor

    There is limited information available on the use of Trinbelimab during driving. Please consult your doctor.

  • Safety Warning

    Liver

    consult your doctor

    Please inform your doctor if you have liver impairment/liver disease before receiving Trinbelimab.

  • Safety Warning

    Kidney

    consult your doctor

    Please inform your doctor if you have kidney disease before receiving Trinbelimab.

  • Safety Warning

    Children

    unsafe

    Trinbelimab is not recommended for children.

Habit Forming

No

Diet & Lifestyle Advise

  • Consume a range of entire grains, lean meats, fruits, veggies, and healthy fats.
  • Ensure you get enough rest and sleep.
  • Avoid alcohol and tobacco, as they can harm your baby.
  • Practice stress-reducing activities like meditation or deep breathing exercises.
  • Drink plenty of water to stay hydrated.
  • Engage in moderate exercise, such as walking or prenatal yoga, unless contraindicated.

Patients Concern

Disease/Condition Glossary

Rh sensitization: Rh sensitization occurs when an individual with Rh-negative blood is exposed to Rh-positive blood, triggering the production of antibodies against the Rh factor. This can happen during pregnancy, blood transfusions, or injuries that mix the two blood types. Initially, there are no noticeable symptoms. However, if sensitization occurs during pregnancy, it can lead to severe complications in future pregnancies. These complications can include jaundice, anemia, hydrops fetalis, and even stillbirth.

FAQs

Trinbelimab is used to prevent Rh sensitization in Rh-negative individuals, especially during pregnancy and after certain medical procedures.

Trinbelimab contains Trinbelimad, which belongs to the class anti-Rh D immunoglobulin. It works by eliminating or neutralizing any Rh D-positive fetal red blood cells that may enter the Rh D-negative mother's bloodstream during childbirth, abortion, or any pregnancy-related complications that could cause bleeding across the placenta.

Trinbelimab is contraindicated in pregnant woman with positive ICT (Indirect Coombs' test), Rh-D positive and should not be given to an infant. Inform your doctor if you are allergic to Trinbelimab. Also inform about all the medicines you are taking and about your pre-existing health conditions.

There are no known side effects to Trinbelimab. However, it may cause local pain, flushing, fever, chills and headache, after administration. Most of these side effects gradually resolve on their own over time. However, please consult your doctor if these symptoms persist or worsen.

Available Medicines for

Trinbelimab

VIEW MORE PRODUCTS
Apollo 247 Floating Button